CryoCor logo — Harnessing the power of cryogenics to restore normal heart f...

CryoCor

Harnessing the power of cryogenics to restore normal heart function with precision and care.

Founded 2000 Series D Total: $92.50M Health Care, Manufacturing

General Information

Company Name CryoCor
Founded Year 2000
Industries Health Care, Manufacturing
Funding Stage Series D
Social

Get notified when CryoCor moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CryoCor

CryoCor is a San Diego-based medical technology company that specializes in the use of cryogenic technology to treat cardiac arrhythmias. Its flagship product, the CryoCor™ Cardiac Cryoablation System, offers a non-surgical, minimally invasive procedure for restoring normal heart function by using cryoablation catheters. These catheters, linked to an articulating arm mounted on the company's refrigeration console, are inserted into a patient's blood vessel and guided to the heart to lower the temperature of the targeted cardiac tissue to around -90°C, thereby blocking abnormal signals that cause irregular heartbeats. Having received approval for use in Europe in 2002, the CryoCor Cardiac Cryoablation System has been commercially available in the region and is currently in use across multiple medical centers. The company's European operations are managed through a wholly-owned subsidiary in Cologne, Germany, which oversees marketing, sales, and post-market clinical activities. In terms of funding, CryoCor secured a notable $46.00M Series D investment on 16 June 2003, with participation from OrbiMed and Oakwood Medical Investors. With its innovative approach to cardiac treatment and established presence in the European market, CryoCor shows promise for continued growth and impact in the healthcare industry.

Taxonomy: cardiac cryoablation, cryogenic technology, minimally invasive procedure, cardiac arrhythmias, non-surgical treatment, heart function restoration, cryoablation catheter, refrigeration console, European approval, clinical activities, san diego, catheter placement, medical centers, heart rhythm disorders

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• 2
Investor Investor
16 Jun 2003
Series C •••••• 3
Investor Investor Investor
06 Jun 2003
Series B •••••• 3
Investor
•••• ••••
28 Jan 2002
Series A •••••• 1
Investor
14 Sep 2000

CryoCor Alternatives & Competitors

CryoCor vs

Lesion Creation at the Speed of Light

Series Unknown
65 employees
Biotechnology, Health Care
CryoCor vs
Endosense
Endosense Switzerland

Endosense is a medical technology company focused on improving the efficacy, safety and reproducibil...

Series C
1 employees
Biotechnology, Health Care
CryoCor vs

To Become The Leading Provider of Comprehensive EP Solution !

Series Unknown
28 employees
Biotechnology, Health Care

FAQ About CryoCor

Harnessing the power of cryogenics to restore normal heart function with precision and care.
CryoCor was founded in 2000.
CryoCor operates in the following industries: Health Care, Manufacturing.
CryoCor has completed 4 funding rounds, raising a total of $92.50M. The latest funding stage is Series D.
Top alternatives and competitors to CryoCor include CardioFocus, Endosense, MicroPort EP, ATS Medical, Inc., CoreValve. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CryoCor and CardioFocus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CryoCor and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes